Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: 5-FU, epirubicin and cyclophosphamide
Sponsor: Henrik Lindman
Collaborators: Scandinavian Breast Group|Danish Breast Cancer Cooperative Group|Swedish Cancer Society|Swedish Cancer Foundation|Pharmacia Pharmaceutical Company|Swedish Breast Cancer Group